Comparative Analysis of Median Nerve Parameters for Carpal Tunnel Syndrome (CTS) Diagnosis: Ultrasound Versus Nerve Conduction Studies (NCS)

Launched by COMBINED MILITARY HOSPITAL KOHAT PAKISTAN · Apr 11, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how well ultrasound can diagnose Carpal Tunnel Syndrome (CTS) compared to a traditional test called Nerve Conduction Studies (NCS). CTS is a condition that causes symptoms like numbness, tingling, or weakness in the hand due to pressure on the median nerve. The researchers want to find out if ultrasound can accurately detect CTS and which measurements of the median nerve from both tests are the most helpful for diagnosis.

To participate in this study, you need to be at least 18 years old and have symptoms of CTS, such as pain or tingling in your hand. You will undergo both an ultrasound and an NCS at the clinic, and the researchers will ask you about your symptoms and medical history. This study aims to improve how we diagnose CTS and see if ultrasound can be a more comfortable and quicker option than the NCS. It’s important to note that people with certain conditions, like previous CTS surgery or other nerve disorders, may not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults aged 18 years or older.
• • 2. Patients with clinical symptoms of CTS, including numbness, tingling, pain, or weakness in the hand.
• • 3. Positive findings on clinical examination, such as Tinel's sign, Phalen's test, or Durkan's test.
• • 4. Willingness to undergo both ultrasound and NCS for diagnostic evaluation.
• Exclusion Criteria:
• • 1. Previous surgery for CTS in the affected hand.
• • 2. History of peripheral neuropathy such as diabetic neuropathy
• • 3. Other neuromuscular disorders affecting the upper limb such as cervical radiculopathy.
• • 4. Pregnant women.
• • 5. Severe comorbid conditions that may interfere with study participation.
• • 6. Inability to provide informed consent.